AGC Biologics Acquires Molecular Medicine S.p.A,
Mergers & Acquisitions
AGC Biologics, a global biopharmaceutical contract development and manufacturing organization, acquired Molecular Medicine S.p.A., a clinical validation and R&D biotechnology company, for $238 million.
Morrow Sodali acted as the information agent for the bidder in this transaction.
Find more information here.